Journal article

2700 Final results of ARIEL2 (Part 1): A phase 2 trial to prospectively identify ovarian cancer (OC) responders to rucaparib using tumor genetic analysis

R Kristeleit, E Swisher, A Oza, RL Coleman, C Scott, G Konecny, A Tinker, DM O'Malley, J Brenton, K Bell-McGuinn, A Oaknin, A Leary, KK Lin, M Raponi, H Giordano, L Maloney, S Goble, R Yelensky, I McNeish

European Journal of Cancer | Elsevier BV | Published : 2015